Intrust Bank’s NuVasive, Inc. NUVA Stock Holding History

Intrust Bank’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,137	Closed	-$241K	–	389
2017 Q2	$241K	Sell	3,137 -150	-5%	-$11.2K	0.08%	337
2017 Q1	$246K	Buy	+3,287	New	+$239K	0.09%	328

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Intrust Bank's NUVA Position: Q3 2017 in Review

Intrust Bank sold out of NuVasive, Inc. (NUVA) in Q3 2017, closing a stake of 3,137 shares — an estimated $241K sold.

Intrust Bank first reported a position in NUVA in Q1 2017 and held it in 2 quarters. The position peaked at $246K in Q1 2017. 263 funds tracked by Wall St. Rank hold NUVA as of Q3 2017.

Intrust Bank reported no remaining NuVasive, Inc. position as of Q3 2017 after selling out during the quarter.
Intrust Bank sold 3,137 NuVasive, Inc. shares in Q3 2017, an estimated $241K.
Intrust Bank first reported a position in NuVasive, Inc. in Q1 2017 and held it in 2 quarters.
Intrust Bank's NuVasive, Inc. position peaked at $246K in Q1 2017.
263 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2017.

Based on Intrust Bank's 13F filing for Q3 2017, filed 6 Nov 2017.